Table 1.
CTRL (n = 24) | CAD (n = 19) | p values | |
---|---|---|---|
Age (years) | 57.0 ± 7.3 | 59.2 ± 8.8 | 0.364 |
Sex, male (%) | 8 (32.0) | 12 (68.0) | 0.054 |
BMI (kg/m2) | 23.7 ± 3.2 | 24.8 ± 2.4 | 0.241 |
AC (cm) | 85.7 ± 10.2 | 89.2 ± 6.8 | 0.278 |
SBP (mmHg) | 117.4 ± 12.1 | 124.8 ± 15.6 | 0.086 |
DBP (mmHg) | 73.1 ± 12.9 | 71.9 ± 6.8 | 0.709 |
CAD | |||
1-vessel disease | 0 (0.0) | 2 (10.5) | |
2-vessel disease | 0 (0.0) | 5 (26.3) | |
3-vessel disease | 0 (0.0) | 12 (63.2) | |
Complications | |||
Diabetes mellitus (%) | 0 (0.0) | 0 (0.0) | 1.000 |
Hypertension (%) | 5 (20.8) | 10 (52.6) | 0.032 |
Hyperlipidemia (%) | 3 (12.5) | 8 (42.1) | 0.029 |
Laboratory measurements | |||
WBC (× 109/L) | 6.3 ± 2.3 | 6.2 ± 1.6 | 0.953 |
HbA1c (%) | 2.7 ± 1.3 | 3.5 ± 2.3 | 0.448 |
TG (mmol/L) | 1.4 ± 1.1 | 2.0 ± 1.2 | 0.085 |
LDL-c (mmol/L) | 2.7 ± 0.6 | 2.7 ± 1.1 | 0.984 |
HDL-c (mmol/L) | 1.1 ± 0.3 | 0.9 ± 0.2 | 0.070 |
Left heart function | |||
EF (%) | 55.2 ± 8.8 | 57.1 ± 11.4 | 0.544 |
Medication | |||
β-blocker | 10 (41.7) | 17 (89.5) | 0.001 |
ACEI/ARB | 8 (33.3) | 9 (47.4) | 0.356 |
Statin | 2 (8.3) | 12 (63.2) | 0.000 |
Data are presented as mean ± SD or the number (%) of patients.
BMI Body Mass Index, AC abdominal circumference, SBP systolic blood pressure, DBP diastolic blood pressure, WBC white blood cell, HbA1c glycated hemoglobin, TGs triglycerides, LDL-c low-density lipoprotein cholesterol, HDL-c high-density lipoprotein cholesterol, EF ejection fraction, ACEI angiotensin-converting enzyme inhibitors, ARB angiotensin receptor blockers.